Last reviewed · How we verify

NCT07307898: w-bems

Cavitaion vs W-BEMS on Central Obesity

Active, enrolled NA Last updated 29 December 2025
What this trial tests

NA trial testing cavitation, whole body electromyostimulation in Central Obesity in 60 participants. Participants enrolled and being followed up; not accepting new ones.

Timeline
5 September 2024
Primary endpoint
5 November 2024
4 January 2026

Quick facts

Lead sponsorCairo University
PhaseNA
StatusActive, enrolled
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposetreatment
Enrollment60
Start date5 September 2024
Primary completion5 November 2024
Estimated completion4 January 2026
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Cairo University

Who can join

Adults 18 to 50, any sex, with Central Obesity. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to compare the effects of ultrasound cavitation and whole-body electromyostimulation (WB-EMS) on inflammatory markers in individuals with central obesity.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Central Obesity

Currently open trials in the same condition.

Other Cairo University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07307898.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing